Cargando…
Systematic evaluation of the pre-eclampsia drugs, dietary supplements and biologicals pipeline using target product profiles
BACKGROUND: The Accelerating Innovation for Mothers (AIM) project established a database of candidate medicines in research and development (R&D) between 2000 and 2021 for five pregnancy-related conditions, including pre-eclampsia. In parallel, we published target product profiles (TPPs) that de...
Autores principales: | McDougall, Annie R. A., Hastie, Roxanne, Goldstein, Maya, Tuttle, Andrew, Tong, Stephen, Ammerdorffer, Anne, Gülmezoglu, A. Metin, Vogel, Joshua P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635102/ https://www.ncbi.nlm.nih.gov/pubmed/36329468 http://dx.doi.org/10.1186/s12916-022-02582-z |
Ejemplares similares
-
New medicines for spontaneous preterm birth prevention and preterm labour management: landscape analysis of the medicine development pipeline
por: McDougall, Annie R. A., et al.
Publicado: (2023) -
Innovations in the prevention and treatment of postpartum hemorrhage: Analysis of a novel medicines development pipeline database
por: McDougall, Annie R.A., et al.
Publicado: (2022) -
Target product profiles for novel medicines to prevent and treat preeclampsia: An expert consensus
por: Mcdougall, Annie Ra, et al.
Publicado: (2022) -
PROVE—Pre-Eclampsia Obstetric Adverse Events: Establishment of a Biobank and Database for Pre-Eclampsia
por: Bergman, Lina, et al.
Publicado: (2021) -
Clinical practice patterns on the use of magnesium sulphate for treatment of pre‐eclampsia and eclampsia: a multi‐country survey
por: Long, Q, et al.
Publicado: (2016)